Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
21.73
+0.32 (1.49%)
At close: Nov 10, 2026, 4:00 PM EST
21.10
-0.63 (-2.90%)
After-hours: Nov 10, 2026, 7:59 PM EST
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.55 billion as of November 10, 2026. It is the 7,776th most valuable company in the world and the 1,940th biggest in the United States. Its market cap has decreased by 22.24% in one year.
Market Cap
1.55B
Enterprise Value
316.42M
1-Year Change
-22.24%
Global Rank
Country Rank
#1,940 United States
Category
ChartMarket Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.55B, an increase of 182.34%. That is a compound annual growth rate of 31.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.55B | -67.78% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ultragenyx Pharmaceutical | 1.64B |
| Precigen | 1.62B |
| Braveheart Bio | 1.60B |
| uniQure | 1.59B |
| Intellia Therapeutics | 1.57B |
| Rapport Therapeutics | 1.54B |
| ADARx Pharmaceuticals | 1.52B |
| Nuvation Bio | 1.49B |